NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 37 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393,032 | +19.2% | 259,000 | 0.0% | 0.00% | – |
| Q2 2023 | $329,739 | -5.0% | 259,000 | 0.0% | 0.00% | – |
| Q1 2023 | $347,029 | -14.7% | 259,000 | 0.0% | 0.00% | – |
| Q4 2022 | $406,765 | +27.9% | 259,000 | +15.1% | 0.00% | – |
| Q3 2022 | $318,000 | +139.1% | 225,000 | +125.0% | 0.00% | – |
| Q3 2021 | $133,000 | -71.9% | 100,000 | -71.0% | 0.00% | – |
| Q1 2021 | $473,000 | -92.2% | 345,000 | -92.2% | 0.00% | -100.0% |
| Q4 2020 | $6,066,000 | +159.6% | 4,400,000 | +147.9% | 0.00% | -25.0% |
| Q2 2019 | $2,337,000 | -0.9% | 1,775,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,359,000 | +35.1% | 1,775,000 | +18.3% | 0.00% | 0.0% |
| Q4 2018 | $1,746,000 | +435.6% | 1,500,000 | +566.7% | 0.00% | +300.0% |
| Q2 2018 | $326,000 | – | 225,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |